Alerts will be sent to your verified email
Verify Email
SHUKRAPHAR
|
Shukra Pharma
|
Lincoln Pharma
|
Kwality Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.12 % | 15.94 % | 25.27 % |
|
5yr Avg Net Profit Margin
|
7.6 % | 14.61 % | 11.66 % |
|
Price to Book
|
18.64 | 1.62 | 3.89 |
|
P/E
|
115.71 | 12.58 | 23.69 |
|
5yr Avg Cash Conversion Cycle
|
-20.3 Days | 24.49 Days | 55.02 Days |
|
5yr Average Interest Coverage Ratio
|
36.02 | 58.2 | 16.13 |
|
5yr Avg ROCE
|
10.67 % | 20.48 % | 34.73 % |
|
5yr Avg Operating Profit Margin
|
15.03 % | 18.48 % | 23.23 % |
|
5 yr average Debt to Equity
|
0.32 | 0.0 | 0.46 |
|
5yr CAGR Net Profit
|
241.36 % | 12.65 % | 21.34 % |
|
5yr Average Return on Assets
|
6.5 % | 12.28 % | 12.96 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
50.96 % | 49.78 % | 54.83 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.79 % | 5.7 % | 0.38 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Shukra Pharma
|
Lincoln Pharma
|
Kwality Pharma
|
|---|